Author: Nourian, Anahid; Khalili, Hossein
Title: Sofosbuvir as a potential option for the treatment of COVID-19 Cord-id: 9vfwqv91 Document date: 2020_5_11
ID: 9vfwqv91
Snippet: Sofosbuvir may be a potential option in the treatment of COVID-19 based on the similarity between the replication mechanisms of the HCV and the coronavirus. According the limited experimental evidences, it is hypothesized that sofosbuvir might be a potential option to improve care of patients with COVID-19 especially at the start of the disease and before invasion of the virus into the lung parenchymal cells. Efficacy and safety of sofosbuvir in treatment of COVID-19 may be considered in future
Document: Sofosbuvir may be a potential option in the treatment of COVID-19 based on the similarity between the replication mechanisms of the HCV and the coronavirus. According the limited experimental evidences, it is hypothesized that sofosbuvir might be a potential option to improve care of patients with COVID-19 especially at the start of the disease and before invasion of the virus into the lung parenchymal cells. Efficacy and safety of sofosbuvir in treatment of COVID-19 may be considered in future clinical studies. (www.actabiomedica.it)
Search related documents:
Co phrase search for related documents- active site and lung kidney cell: 1
Co phrase search for related documents, hyperlinks ordered by date